Clincosm LogoSign in Get a demo

mantle cell lymphoma

Showing NaN - NaN of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mantle Cell Lymphoma, Untreated Trial in United States (Lenalidomide, R-CHOP, high-dose cytarabine (HIDAC))

Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Basking Ridge, New Jersey
  • +6 more
Feb 17, 2022

Mantle Cell Lymphoma, Lymphoma Trial in United States (BR-I (bendamustine, rituximab, ibrutinib), VEN (Venetoclax))

Active, not recruiting
  • Mantle Cell Lymphoma
  • Lymphoma
  • BR-I (bendamustine, rituximab, ibrutinib)
  • VEN (Venetoclax)
  • Basking Ridge, New Jersey
  • +6 more
Feb 3, 2022

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
Has Results
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Mantle Cell Lymphoma Trial in New York (Acalabrutinib, Lenalidomide, Rituximab)

Recruiting
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
Oct 29, 2021

DLBCL, Mantle Cell Lymphoma, Follicular Lymphoma Trial in Spain, United States (Loncastuximab Tesirine and Durvalumab)

Terminated
Has Results
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Loncastuximab Tesirine and Durvalumab
  • Birmingham, Alabama
  • +13 more
Sep 28, 2021

Mantle Cell Lymphoma Trial in United States (Ofatumumab (This arm is closed), Ofatumumab + Bendamustine)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Ofatumumab (This arm is closed)
  • Ofatumumab + Bendamustine
  • Basking Ridge, New Jersey
  • +5 more
Oct 1, 2021

Follicular Lymphoma, Mantle Cell Lymphoma Trial in New York (Ribavirin)

Terminated
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2021

Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma Trial in Canada, United States (ABT-263)

Completed
  • Chronic Lymphoid Leukemia
  • +5 more
  • Los Angeles, California
  • +11 more
Jul 28, 2021

Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)

Recruiting
  • Cancer, Metastatic
  • +42 more
  • Clinical Trial Matching
  • New York, New York
    Massive Bio, Inc
May 21, 2021

Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York

Completed
Has Results
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • Tucson, Arizona
  • +2 more
Mar 23, 2021

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Entospletinib MM
  • Entospletinib SDD
  • Birmingham, Alabama
  • +47 more
Nov 2, 2020

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in United States (Entospletinib,

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • La Jolla, California
  • +12 more
May 18, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Worldwide (Lenalidomide, Placebo)

Terminated
Has Results
  • Mantle Cell Lymphoma
  • Non-Hodgkin's Lymphoma
  • San Diego, California
  • +91 more
Nov 6, 2019

Mantle Cell Lymphoma Trial in New York (PD 0332991, bortezomib)

Terminated
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medical College
Jun 25, 2019

Mantle Cell Lymphoma Trial in Worldwide (lenalidomide)

Completed
Has Results
  • Mantle Cell Lymphoma
  • Little Rock, Arkansas
  • +69 more
Dec 11, 2018

DLBCL, Transformed Follicular Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Alisertib (MLN8237), Rituximab, Vincristine)

Completed
Has Results
  • Diffuse Large B-Cell Lymphoma
  • +3 more
  • Alisertib (MLN8237)
  • +2 more
  • Tucson, Arizona
  • +24 more
Feb 27, 2018

CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in

Completed
  • CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma
  • +9 more
  • Scottsdale, Arizona
  • +9 more
Jan 29, 2018

Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

Completed
  • Mantle Cell Lymphoma
  • La Jolla, California
  • +56 more
May 27, 2016

Mantle Cell Lymphoma Trial in Worldwide (PCI-32765)

Completed
Has Results
  • Mantle Cell Lymphoma
  • Stanford, California
  • +17 more
Aug 24, 2015

Hodgkin Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Canada, United States (SB1518)

Completed
  • Hodgkin Lymphoma
  • +2 more
  • Omaha, Nebraska
  • +4 more
Apr 19, 2012

Follicular Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma Trial in United States (AT-101)

Completed
  • Follicular Lymphoma
  • +4 more
  • Birmingham, Alabama
  • +10 more
Jun 24, 2011

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma Trial in United States (Leuprolide acetate depot (LAD) 11.25 mg 3

Terminated
Has Results
  • Hodgkin Disease
  • +3 more
  • Leuprolide acetate depot (LAD) 11.25 mg 3 Month
  • Matched placebo
  • Saint Louis, Missouri
  • +3 more
Apr 9, 2010

Mantle Cell Lymphoma Trial in United States (VELCADE TM (bortezomib) for Injection)

Completed
  • Mantle Cell Lymphoma
  • VELCADE TM (bortezomib) for Injection
  • Birmingham, Alabama
  • +34 more
Feb 7, 2008